6-87155652-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The NM_015021.3(ZNF292):c.61G>C(p.Glu21Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E21K) has been classified as Uncertain significance.
Frequency
Consequence
NM_015021.3 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
- intellectual developmental disorder, autosomal dominant 64Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF292 | NM_015021.3 | c.61G>C | p.Glu21Gln | missense_variant | Exon 1 of 8 | ENST00000369577.8 | NP_055836.1 | |
ZNF292 | NM_001351444.2 | c.-505G>C | 5_prime_UTR_variant | Exon 1 of 9 | NP_001338373.1 | |||
ZNF292 | XM_047418459.1 | c.-673G>C | 5_prime_UTR_variant | Exon 1 of 10 | XP_047274415.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Intellectual developmental disorder, autosomal dominant 64 Pathogenic:1
This variant has been identified by standard clinical testing. de novo Selected ACMG criteria: Likely pathogenic (II):BP1;PM2;PS2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at